• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Does PTH offer additive value to ALP measurement in assessing CKD-MBD?

作者信息

Lamb Edmund J, Delaney Michael P

机构信息

Clinical Biochemistry, Kent Kidney Care Centre, East Kent Hospitals University NHS Foundation Trust, Canterbury, Kent, CT1 3NG, UK

Clinical Biochemistry, Kent Kidney Care Centre, East Kent Hospitals University NHS Foundation Trust, Canterbury, Kent, CT1 3NG, UK.

出版信息

Perit Dial Int. 2014 Nov-Dec;34(7):687-91. doi: 10.3747/pdi.2014.00246.

DOI:10.3747/pdi.2014.00246
PMID:25520480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4269492/
Abstract
摘要

相似文献

1
Does PTH offer additive value to ALP measurement in assessing CKD-MBD?在评估慢性肾脏病-矿物质和骨异常（CKD-MBD）时，甲状旁腺激素（PTH）相对于碱性磷酸酶（ALP）测量是否具有附加价值？
Perit Dial Int. 2014 Nov-Dec;34(7):687-91. doi: 10.3747/pdi.2014.00246.
2
Alkaline Phosphatase, iPTH and Bone Turnover Markers in Chinese Advanced Chronic Kidney Disease Patients.中国晚期慢性肾脏病患者的碱性磷酸酶、甲状旁腺激素及骨转换标志物
Clin Lab. 2015;61(7):839-43. doi: 10.7754/clin.lab.2015.141101.
3
Adherence to Kidney Disease: Improving Global Outcomes Mineral and Bone Guidelines for Monitoring Biochemical Parameters.遵守肾脏病：改善全球肾脏病预后组织矿物质和骨代谢异常诊治指南监测生化参数。
Am J Nephrol. 2019;49(3):225-232. doi: 10.1159/000497477. Epub 2019 Feb 28.
4
Activin A: a marker of mineral bone disorder in children with chronic kidney disease?激活素 A：慢性肾脏病儿童矿物质骨代谢紊乱的标志物？
Pediatr Nephrol. 2024 Sep;39(9):2773-2777. doi: 10.1007/s00467-024-06400-x. Epub 2024 May 14.
5
Parathyroid hormone as a marker for metabolic bone disease of prematurity.甲状旁腺激素作为早产儿代谢性骨病的标志物。
J Perinatol. 2014 Oct;34(10):787-91. doi: 10.1038/jp.2014.97. Epub 2014 May 29.
6
Trends of elevated parathormone serum titers in hemodialysis patients on intensive therapy for bone disease: a multicenter study.接受骨病强化治疗的血液透析患者血清甲状旁腺激素水平升高的趋势：一项多中心研究
Saudi J Kidney Dis Transpl. 2014 Nov;25(6):1166-77. doi: 10.4103/1319-2442.144249.
7
Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.骨转换率低与非低的血液透析患者的骨碱性磷酸酶同工型：一项诊断试验研究
Am J Kidney Dis. 2015 Jul;66(1):99-105. doi: 10.1053/j.ajkd.2015.02.323. Epub 2015 Apr 2.
8
Fractures in patients with CKD-diagnosis, treatment, and prevention: a review by members of the European Calcified Tissue Society and the European Renal Association of Nephrology Dialysis and Transplantation.CKD 患者的骨折：欧洲钙化组织协会和欧洲肾脏协会肾脏病透析与移植分会成员的综述
Kidney Int. 2017 Dec;92(6):1343-1355. doi: 10.1016/j.kint.2017.07.021. Epub 2017 Sep 28.
9
Association of parathormone and alkaline phosphatase with bone turnover and mineralization in children with CKD on dialysis: effect of age, gender, and race.甲状旁腺激素和碱性磷酸酶与透析治疗的慢性肾脏病儿童的骨转换和矿化的关系：年龄、性别和种族的影响。
Pediatr Nephrol. 2020 Jul;35(7):1297-1305. doi: 10.1007/s00467-020-04499-2. Epub 2020 Mar 10.
10
The complexity of chronic kidney disease-mineral and bone disorder across stages of chronic kidney disease.慢性肾脏病-矿物质和骨异常在慢性肾脏病各阶段的复杂性。
Kidney Int. 2017 Jun;91(6):1436-1446. doi: 10.1016/j.kint.2016.12.029. Epub 2017 Mar 18.

引用本文的文献

1
Carotid intima-media thickness, fibroblast growth factor 23, and mineral bone disorder in children with chronic kidney disease.儿童慢性肾脏病患者的颈动脉内膜中层厚度、成纤维细胞生长因子 23 与矿物质骨代谢紊乱。
BMC Nephrol. 2024 Oct 21;25(1):369. doi: 10.1186/s12882-024-03771-z.
2
Stabilization of serum alkaline phosphatase in hemodialysis patients by implementation of local chronic kidney disease-mineral bone disorder management strategy: A quality improvement study.通过实施局部慢性肾脏病-矿物质和骨异常管理策略稳定血液透析患者血清碱性磷酸酶水平：一项质量改进研究。
Kidney Res Clin Pract. 2018 Jun;37(2):157-166. doi: 10.23876/j.krcp.2018.37.2.157. Epub 2018 Jun 30.
3
Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.碱性磷酸酶：CKD 心血管疾病的新治疗靶点。
Nat Rev Nephrol. 2017 Jul;13(7):429-442. doi: 10.1038/nrneph.2017.60. Epub 2017 May 15.

本文引用的文献

1
Inter-method variability in bone alkaline phosphatase measurement: clinical impact on the management of dialysis patients.骨碱性磷酸酶测量的方法间变异性：对透析患者管理的临床影响。
Clin Biochem. 2014 Sep;47(13-14):1227-30. doi: 10.1016/j.clinbiochem.2014.04.007. Epub 2014 Apr 15.
2
Alkaline phosphatase and mortality in patients on peritoneal dialysis.腹膜透析患者的碱性磷酸酶与死亡率
Clin J Am Soc Nephrol. 2014 Apr;9(4):771-8. doi: 10.2215/CJN.08280813. Epub 2014 Jan 23.
3
Comparative mortality-predictability using alkaline phosphatase and parathyroid hormone in patients on peritoneal dialysis and hemodialysis.使用碱性磷酸酶和甲状旁腺激素对腹膜透析和血液透析患者进行死亡率预测的比较
Perit Dial Int. 2014 Nov-Dec;34(7):732-48. doi: 10.3747/pdi.2013.00110. Epub 2014 Jan 2.
4
Relationship between alkaline phosphatase and all-cause mortality in peritoneal dialysis patients.腹膜透析患者碱性磷酸酶与全因死亡率的关系。
Adv Perit Dial. 2013;29:61-3.
5
Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review.影响血液样本中甲状旁腺激素测量的采样和存储条件：系统评价。
Clin Chem Lab Med. 2013 Oct;51(10):1925-41. doi: 10.1515/cclm-2013-0315.
6
Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.氧化型甲状旁腺激素（oxPTH）和未氧化型甲状旁腺激素（n-oxPTH）受体结合的建模及慢性肾衰竭儿童、血液透析成年患者和肾移植受者中氧化型与未氧化型 PTH 的关系。
Kidney Blood Press Res. 2013;37(4-5):240-51. doi: 10.1159/000350149. Epub 2013 Jul 14.
7
Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.在临床人群中，CKD 3-4 期血清碱性磷酸酶的预后意义。
Am J Kidney Dis. 2013 Oct;62(4):703-10. doi: 10.1053/j.ajkd.2013.04.012. Epub 2013 Jun 12.
8
Bone alkaline phosphatase in CKD-mineral bone disorder.慢性肾脏病-矿物质和骨异常中的骨碱性磷酸酶。
Am J Kidney Dis. 2013 Oct;62(4):810-22. doi: 10.1053/j.ajkd.2013.02.366. Epub 2013 Apr 23.
9
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis.西那卡塞对透析患者心血管疾病的影响。
N Engl J Med. 2012 Dec 27;367(26):2482-94. doi: 10.1056/NEJMoa1205624. Epub 2012 Nov 3.
10
Association of pre-kidney transplant markers of mineral and bone disorder with post-transplant outcomes.移植前矿物质和骨代谢紊乱标志物与移植后结局的相关性。
Clin J Am Soc Nephrol. 2012 Nov;7(11):1859-71. doi: 10.2215/CJN.01910212. Epub 2012 Sep 6.